Inducing immunogenic cell death in immuno-oncological therapies

Immunotherapy has revolutionized cancer treatment and substantially improved patient outcomes with respect to multiple types of tumors. However, most patients cannot benefit from such therapies, mainly due to the intrinsic low immunogenicity of cancer cells (CCs) that allows them to escape recogniti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ti, Dongdong, Yan, Xin, Wei, Jianshu, Wu, Zhiqiang, Wang, Yao, Han, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913252/
https://www.ncbi.nlm.nih.gov/pubmed/35355932
http://dx.doi.org/10.21147/j.issn.1000-9604.2022.01.01

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913252/
https://www.ncbi.nlm.nih.gov/pubmed/35355932
http://dx.doi.org/10.21147/j.issn.1000-9604.2022.01.01

Ejemplares similares